Health ❯ Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Phase 3 Trials

aTyr Pharma Secures FDA Agreement on Phase 3 Protocol for Efzofitimod in Pulmonary Sarcoidosis

FDA alignment lets the company plan a 54-week, 372-patient global trial beginning in Q4 2026 that will measure lung function at week 48.

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of High‑Risk CSCC

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study